Cyclosporin (CSA)

DRUG4 trials

Sponsors

Eastern Cooperative Oncology Group, Cairo University, Erasmus Medical Center, Peking Union Medical College Hospital

Conditions

Alopecia Areata (& Ophiasis)Alopecia Areata (AA)Alopecia Areata(AA)Alopecia Totalis (AT)Alopecia Totalis/UniversalisAlopecia Universalis (AU)LymphomaPsoriasis

Phase 1

Combined Use of Cyclosporine and Metformin in Treatment of Psoriasis vs Cyclosporine Alone

CompletedNCT07375654

Cairo UniversityPsoriasis

Start: 2024-12-19End: 2025-11-04Updated: 2026-01-29

Phase 2

Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

TerminatedNCT00057954

Eastern Cooperative Oncology GroupLymphoma

Start: 2005-11-09End: 2011-05-31Updated: 2023-06-28

Phase 3

Enarodustat+CsA vs CsA in the Treatment of Newly-diagnosed TD-NSAA

Not yet recruitingNCT07522996

Peking Union Medical College HospitalTransfusion-dependent Non-severe Aplastic Anemia

Start: 2026-04-01End: 2029-12-01Target: 90Updated: 2026-04-13

Phase 4

Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

RecruitingNCT07381556

Erasmus Medical CenterAlopecia Areata (AA), Alopecia Areata(AA), Alopecia Areata (& Ophiasis) +3

Start: 2025-11-01End: 2027-11-01Target: 50Updated: 2026-02-02